The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded Drs. Alan D’Andrea and James Cleary $1 million in initial funding to evaluate DNA repair inhibitors in pancreatic cancer. Read the story.
Pancreatic Cancer Collective awards Dana-Farber Cancer Institute researchers “New Therapies Challenge” grant
November 20, 2018